The effects of lobbying on the FDA’s recall classification
Abstract Background The US Food and Drug Administration (FDA) regulates goods accounting for 20% of US consumers’ total expenditure. The agency’s potential susceptibility to corporate lobbying and political influence may adversely affect the its abilities to fulfill its duties as a vital federal age...
שמור ב:
| מחבר ראשי: | |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
BMC
2023-06-01
|
| סדרה: | BMC Medical Ethics |
| נושאים: | |
| גישה מקוונת: | https://doi.org/10.1186/s12910-023-00921-0 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|